Moukette B, Kawaguchi S, Sepulveda M, Hayasaka T, Aonuma T, Liangpunsakul S
Cell Death Discov. 2022; 8(1):504.
PMID: 36585403
PMC: 9803679.
DOI: 10.1038/s41420-022-01295-9.
Sabu S, Seshadri S, Thunga G, Poojari P, Acharya L
J Pharm Bioallied Sci. 2020; 12(1):48-56.
PMID: 32801600
PMC: 7398002.
DOI: 10.4103/jpbs.JPBS_168_19.
Na E, Cho S, Kim D, Choi J, Han E
Cardiovasc Diabetol. 2020; 19(1):67.
PMID: 32416728
PMC: 7231413.
DOI: 10.1186/s12933-020-01037-0.
Lee S, Sung J, Cho I, Kim H, Chang H
PLoS One. 2018; 13(4):e0195459.
PMID: 29630642
PMC: 5891021.
DOI: 10.1371/journal.pone.0195459.
Imbalzano E, Vatrano M, Quartuccio S, Di Stefano R, Aragona C, Mamone F
Mol Cell Biochem. 2017; 430(1-2):91-98.
PMID: 28190172
DOI: 10.1007/s11010-017-2957-5.
Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes.
Lip S, Jeemon P, McCallum L, Dominiczak A, McInnes G, Padmanabhan S
Eur Heart J. 2015; 37(12):968-74.
PMID: 26508167
PMC: 5841224.
DOI: 10.1093/eurheartj/ehv557.
Reduced total and cause-specific mortality from walking and running in diabetes.
Williams P
Med Sci Sports Exerc. 2014; 46(5):933-9.
PMID: 24968127
PMC: 4157907.
DOI: 10.1249/MSS.0000000000000197.
Walking and running produce similar reductions in cause-specific disease mortality in hypertensives.
Williams P
Hypertension. 2013; 62(3):485-91.
PMID: 23940195
PMC: 4090350.
DOI: 10.1161/HYPERTENSIONAHA.113.01608.
Targeting hypertension in patients with cardiorenal metabolic syndrome.
Rojas E, Velasco M, Bermudez V, Israili Z, Bolli P
Curr Hypertens Rep. 2012; 14(5):397-402.
PMID: 22846983
DOI: 10.1007/s11906-012-0292-5.
Effect of intensive multifactorial treatment on the intima-media thickness of large arteries in patients with new-onset type 2 diabetes mellitus.
Zhao X, Xu Z, Zhang Q, Gu H, Yang Y
J Zhejiang Univ Sci B. 2012; 13(5):378-85.
PMID: 22556176
PMC: 3348229.
DOI: 10.1631/jzus.B1100302.
Management of diabetic hypertensives.
Ganesh J, Viswanathan V
Indian J Endocrinol Metab. 2011; 15 Suppl 4:S374-9.
PMID: 22145142
PMC: 3230084.
DOI: 10.4103/2230-8210.86982.
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
Smith S, Gong Y, Turner S, Cooper-DeHoff R, Beitelshees A, Chapman A
Am J Hypertens. 2011; 25(3):359-65.
PMID: 22089105
PMC: 3288583.
DOI: 10.1038/ajh.2011.215.
Lipid effects of antihypertensive medications.
Deano R, Sorrentino M
Curr Atheroscler Rep. 2011; 14(1):70-7.
PMID: 22037772
DOI: 10.1007/s11883-011-0214-z.
Effects of olmesartan on blood pressure and insulin resistance in hypertensive patients with sleep-disordered breathing.
Dohi T, Narui K, Kasai T, Takaya H, Inoshita A, Maeno K
Heart Vessels. 2011; 26(6):603-8.
PMID: 21221601
DOI: 10.1007/s00380-010-0104-2.
Pleiotropic effects of inhibitors of the RAAS in the diabetic population: above and beyond blood pressure lowering.
Ismail H, Mitchell R, McFarlane S, Makaryus A
Curr Diab Rep. 2010; 10(1):32-6.
PMID: 20425064
DOI: 10.1007/s11892-009-0081-y.
Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.
Hayden M, Sowers J
J Am Soc Hypertens. 2010; 2(4):239-66.
PMID: 20409906
PMC: 2867460.
DOI: 10.1016/j.jash.2007.12.002.
Risk of endometrial cancer in relation to medical conditions and medication use.
Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick K, Faulkner S
Cancer Epidemiol Biomarkers Prev. 2009; 18(5):1448-56.
PMID: 19383893
PMC: 2763278.
DOI: 10.1158/1055-9965.EPI-08-0936.
Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.
Sharma S, Ruggenenti P, Remuzzi G
Vasc Health Risk Manag. 2007; 3(4):453-65.
PMID: 17969376
PMC: 2291330.
Metabolic safety of antihypertensive drugs: myth versus reality.
Stas S, Appesh L, Sowers J
Curr Hypertens Rep. 2006; 8(5):403-8.
PMID: 16965727
DOI: 10.1007/s11906-006-0086-8.
Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?.
Sarafidis P, Bakris G
J Clin Hypertens (Greenwich). 2006; 8(5):351-6.
PMID: 16687944
PMC: 8109409.
DOI: 10.1111/j.1524-6175.2005.04679.x.
